System Biosciences (SBI) specializes in innovative technologies aimed at advancing research in various fields, including exosome studies, gene delivery, and biomarker research. Their product offerings include the EV-Luminite™ system, which allows for the endogenous tagging of extracellular vesicles (EVs) with luciferase to monitor their biogenesis and intercellular communication. Additionally, SBI provides the AAVS1 SparQ™ All-In-One Inducible System for precise gene modulation in mammalian cells, as well as advanced kits for the isolation and characterization of small extracellular vesicles (sEVs) and bacterial outer membrane vesicles (OMVs). Their ExoELISA-ULTRA kits facilitate the quantification of these vesicles, enhancing the study of their roles in various biological processes.

SBI also offers a comprehensive range of gene expression systems, including lentiviral and non-viral vectors, which support high transgene expression levels. Their CRISPR/Cas9 systems provide tools for genome editing, enabling researchers to deliver Cas9 and gRNA effectively. Furthermore, SBI's liquid biopsy products enhance biomarker discovery, while their extensive miRNA and lncRNA research tools support profiling and overexpression studies. With a commitment to innovation, SBI continues to develop cutting-edge technologies that empower scientists worldwide to accelerate their research and discoveries.

United States

At SBI, our mission is to accelerate your science by turning the latest insights and technologies into robust research products and services to advance exosome studies, biomarker research, gene delivery, SARS-CoV-2 studies, and more.

System Biosciences (SBI)

Company Details